former chief financial officer (6) · Aldeyra Therapeutics, Inc. (ALDX)

Stephen Tulipano

A named executive officer of Aldeyra Therapeutics in every fiscal year CompBrief holds from FY2017 to FY2018. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2018

$884,368

Salary $356,296Stock awards $0

FY2017: $1,283,691

4th of 4 named executive officers at Aldeyra Therapeutics by FY2018 total.

4 named officers on file for Aldeyra Therapeutics, FY2018

Stephen Tulipano’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Aldeyra Therapeutics’s whole pay program stands against its peers

  • Aldeyra Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ALDX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 22, 2019 (DEF 14A).

Free

Get Stephen Tulipano’s full pay file as a PDF — free

More than this page: up to 10 years of Stephen’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Stephen Tulipano compensation by year

Aldeyra Therapeutics Summary Compensation Table · all 2 fiscal years held
In US dollars, as Aldeyra Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018
Salary$324,005$356,296
Bonus$0$0
Stock awards$0$0
Option awards$844,702$397,801
Non-equity incentive$114,984$124,704
Pension and deferred compensation$0$0
All other$0$5,567
Total$1,283,691$884,368

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Aldeyra Therapeutics, Inc. DEF 14A filed April 22, 2019, accession 0001564590-19-012248, and prior-year filings.

How this page was built: the Aldeyra Therapeutics, Inc. filed document, accession 0001564590-19-012248. Every figure is read from that document and cited to the page and table it appears in. Filed April 22, 2019.

$1.3M
$884K
FY17
FY18
SalaryNon-equity incentiveOption awardsAll other

Equity holdings

unvested awards at FY2018 year-end
TypeUnvested unitsValue at year-endExercise price
Option96,871—$8.60
Option115,094—$5.10
Option521—$7.85
Option8,125—$4.59

Per the Outstanding Equity Awards at Fiscal Year-End table in Aldeyra Therapeutics, Inc.'s FY2018 proxy; value at the fiscal year-end close, as the company printed it.

Aldeyra Therapeutics’s named executive officers, FY2018

as the company reported each
Named executive officerRoleFY2018 total
Todd BradyPresident and Chief Executive Officer$2,874,355
David McMullinChief Commercial Officer (3)$1,584,445
David ClarkChief Medical Officer$1,202,323
Stephen Tulipano · this pageformer chief financial officer (6)$884,368

The full Aldeyra Therapeutics compensation record

free company brief

This page is one person within Aldeyra Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Aldeyra Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Stephen Tulipano's compensation dossier · One-time report. No refunds.